upadacitinibPBOUPA
…978520) was to evaluate the achievement of LLDAS and DORIS with upadacitinib (UPA) monotherapy (30 mg) vs placebo (PBO).Methods LLDAS and DO…
39articles mentioning drugs
130drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Upadacitinib ×
Upadacitinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning Upadacitinib
39 articles · page 4 of 4filgotinibupadacitinibJAKisbaricitinibtofacitinibUPATOFBARFIL
…s; tofacitinib (TOF), baricitinib (BAR), upadacitinib (UPA) and filgotinib (FIL)) in patients with rheumatoid arthritis (RA) in real-world…
upadacitinibRinvoqPalmoplantar pustulosisNewcastle North Tyneside 2 Research Ethics CommitteeQuintet Recruitment InterventionJanus kinase (JAK) inhibitors
…(n=20) will receive 8 weeks of treatment with the JAK inhibitor upadacitinib (‘Rinvoq’, 30 mg, once daily). Qualitative semistructured inter…